BLUF

GLIDE will accelerate therapeutic options in compression, IR, microsurgery, and other minimally invasive technologies. Additionally, GLIDE will support the development of targeted pharmacologic gene, and cell therapies that directly target mechanisms of lymphatic dysfunction to modulate tissue contractility and vessel growth.